- 英文名称
- 6-O-Methyl-2',4''-bis-O-(trimethylsilyl)erythromycin 9-[O-(1-ethoxy-1-methylethyl)oxime]
- 分子式
- C49H96N2O14Si2
- 分子量
- 993.46
- 中文别名
- 克拉霉素中间体; 克拉霉素甲基物; 硅醚保护产物; 乙氧基-M3; 甲氧基-M3; 红霉素肟(克拉霉素中间体); 9-[-O-(1-甲氧基-1-甲基乙基)肟]; 红霉素,6-O-甲基-二-O-(三甲基硅醚),9-[-O-(1-乙氧基-1-甲基乙基)肟]; 6-O-甲基-2,4-双-O-(三甲基甲硅烷基),9-[O-(1-乙氧基-1-甲基乙基)肟]; Intermediate of Clarithromycin; Erythromycin,6-O-methyl-2`,4``-bis-O-(trimethylsilyl),9-[O-(1-ethoxy-1-methylethyl)oxime; 9-[O-(1-ethoxy-1-methylethy)oxime; 6-O-Methyl-2',4''-bis-O-(trimethylsilyl)-9-[O-(1-ethoxy-1-methylethyl)oxime]-Erythromycin; Erythromycin Impurity 11; CLARITHROMYCIN INTERMEDIATES; (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-({(2S,3R,4S,6R)-4-(Dimethylamino)-6-methyl-3-[(trimethylsilyl)oxy]tetrahydro-2H-pyran-2-yl}oxy)-10-{[(2-ethoxy-2-propanyl)oxy]imino}-14-ethyl-12,13-dihydroxy-7-methoxy-4-({(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-[(trimethylsilyl)oxy]tetrahydro-2H-pyran-2-yl}oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
- 用途
- 作为红霉素A衍生物的中间体，用于医药合成中特定官能团保护与修饰，如2',4''-O-双（三甲基甲硅烷基）-6-O-甲基红霉素A 9-[O-（1-乙氧基-1-甲基乙基肟）]的制备。
